<DOC>
	<DOCNO>NCT00288509</DOCNO>
	<brief_summary>The aim study assess long term safety effectiveness Dysport® .</brief_summary>
	<brief_title>Open-label Extension Study AbobotulinumtoxinA ( Dysport® ) Treatment Cervical Dystonia</brief_title>
	<detailed_description />
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>Torticollis</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>Subjects enrol Y4752120051 study , complete study visit Week 12 , Week 4 event early withdrawal Returned pretreatment status judge Investigator Pure anterocollis pure retrocollis Known antibody botulinum toxin type A Requirement botulinum toxin injection site ( ) neck unable avoid treatment duration study Known significant underlie swallow respiratory abnormality might exacerbate botulinum toxin treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>